Spinal Muscular Atrophy Research
Scholar Rock Inc. focuses its clinical research on spinal muscular atrophy (SMA), with studies centered on both pediatric and older patient groups affected by this neuromuscular disorder.
- Type 2 SMA
- Type 3 SMA
- Infantile SMA
The sponsor’s trial portfolio reflects interest in muscle weakness, muscle atrophy, and the functional impact of SMA across early childhood and later disease stages.
Motor Function and Functional Outcomes
Clinical research activities include assessment of motor function and related functional outcomes in individuals living with SMA, with emphasis on changes relevant to movement, strength, and daily physical abilities.
- Motor performance
- Physical function
- Neuromuscular strength
These studies support investigation of therapeutic effects on functional impairment associated with motor neuron disease.
Early-Life and Pediatric Neuromuscular Care
Scholar Rock Inc. also pursues research in very young children with SMA, including subjects under 2 years of age, highlighting interest in early disease presentation and treatment response during infancy and toddlerhood.
- Infant neuromuscular disease
- Early developmental motor outcomes
- Pediatric SMA
This area of work reflects attention to the clinical needs of pediatric patients with severe hereditary muscle disease.
Long-Term Safety and Tolerability
The sponsor’s research landscape includes ongoing evaluation of long-term safety and tolerability in people with SMA, supporting continued study of chronic treatment use in a genetic neuromuscular condition.
- Safety monitoring
- Tolerability assessment
- Chronic treatment use
These investigations are relevant to sustained care in patients with persistent skeletal muscle weakness and progressive functional limitation.
